LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy

Rebecca Ibrahim, Khalil Saleh, Claude Chahine, Rita Khoury, Nadine Khalife, Axel Le Cesne

Open source

DOI
10.3390/biomedicines11071878
Published
2023-07-01
Container
Biomedicines
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines11071878,
  title = {LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy},
  author = {Rebecca Ibrahim and Khalil Saleh and Claude Chahine and Rita Khoury and Nadine Khalife and Axel Le Cesne},
  year = {2023},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines11071878},
  url = {https://doi.org/10.3390/biomedicines11071878}
}

RIS

TY  - JOUR
TI  - LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy
AU  - Rebecca Ibrahim
AU  - Khalil Saleh
AU  - Claude Chahine
AU  - Rita Khoury
AU  - Nadine Khalife
AU  - Axel Le Cesne
PY  - 2023
JO  - Biomedicines
DO  - 10.3390/biomedicines11071878
UR  - https://doi.org/10.3390/biomedicines11071878
ER  - 

APA

Ibrahim, R., Saleh, K., Chahine, C., Khoury, R., Khalife, N., & Cesne, A. L. (2023). LAG-3 Inhibitors: Novel Immune Checkpoint Inhibitors Changing the Landscape of Immunotherapy. Biomedicines. https://doi.org/10.3390/biomedicines11071878

Source records